American Association for Cancer Research
Browse
cir-23-0440_supplementary_video_2_suppsv2.mp4 (5.73 MB)

Supplementary video 2 from Engagement of CD99 Activates Distinct Programs in Ewing Sarcoma and Macrophages

Download (5.73 MB)
media
posted on 2024-02-02, 08:20 authored by Maria Cristina Manara, Cristina Manferdini, Camilla Cristalli, Marianna Carrabotta, Spartaco Santi, Alessandra De Feo, Giulia Caldoni, Michela Pasello, Lorena Landuzzi, Pier-Luigi Lollini, Francesca Salamanna, Sabrina Dominici, Valentina Fiori, Mauro Magnani, Gina Lisignoli, Katia Scotlandi

Video 2 12E7

Funding

Fondazione AIRC per la ricerca sul cancro ETS (AIRC)

History

ARTICLE ABSTRACT

Ewing sarcoma (EWS) is the second most common pediatric bone tumor. The EWS tumor microenvironment is largely recognized as immune-cold, with macrophages being the most abundant immune cells and their presence associated with worse patient prognosis. Expression of CD99 is a hallmark of EWS cells, and its targeting induces inhibition of EWS tumor growth through a poorly understood mechanism. In this study, we analyzed CD99 expression and functions on macrophages and investigated whether the concomitant targeting of CD99 on both tumor and macrophages could explain the inhibitory effect of this approach against EWS. Targeting CD99 on EWS cells downregulated expression of the “don't eat-me” CD47 molecule but increased levels of the “eat-me” phosphatidyl serine and calreticulin molecules on the outer leaflet of the tumor cell membrane, triggering phagocytosis and digestion of EWS cells by macrophages. In addition, CD99 ligation induced reprogramming of undifferentiated M0 macrophages and M2-like macrophages toward the inflammatory M1-like phenotype. These events resulted in the inhibition of EWS tumor growth. Thus, this study reveals what we believe to be a previously unrecognized function of CD99, which engenders a virtuous circle that delivers intrinsic cell death signals to EWS cells, favors tumor cell phagocytosis by macrophages, and promotes the expression of various molecules and cytokines, which are pro-inflammatory and usually associated with tumor regression. This raises the possibility that CD99 may be involved in boosting the antitumor activity of macrophages.

Usage metrics

    Cancer Immunology Research

    Licence

    Exports

    RefWorks
    BibTeX
    Ref. manager
    Endnote
    DataCite
    NLM
    DC